PROMOTING ACCESS TO AFRICAN RESEARCH

Tropical Journal of Pharmaceutical Research

Log in or Register to get access to full text downloads.

Remember me or Register



Protective effects of Zhuifeng tougu on collagen-induced arthritis in DBA/1 mice

Wenyi Qin, Jiarong Zhong, Xiaofeng Rong, Yu Zhong

Abstract


Purpose: To investigate the protective effects of Zhuifengtougu (ZFTG) on rheumatoid arthritis (RA) using collagen-induced arthritis (CIA) mouse model

Methods: DBA/1 mice were randomly divided into 7 treatment groups (n = 8): normal, positive control (CIA mice), CIA mice + total glucosides of peony (TGP), CIA mice + cyclophosphamide (CPA), CIA mice + 100 mg/kg ZFTG, CIA mice + 200 mg/kg ZFTG, and CIA mice + 400 mg/kg ZFTG. The serum levels of interleukin (IL)-1β, IL-6, IL-10, IL-17 and tumor necrosis factor (TNF)-αwere measured by enzyme-linked immunosorbent assay (ELISA). Western blot was used to determine the protein expression of B-cell lymphoma 2 (BCL-2), p53 and first apoptosis signal receptor (Fas).

Results: Following drug administration, the arthritic index in CIA mice administered low-dose, mediumdose, or high-dose ZFTG (1.53 – 1.87), TGP (1.75 ± 0.42), or CPA (1.52 ± 0.36) was reduced significantly (p < 0.05), compared with positive control group (5.66 ± 0.73; p < 0.01). Levels of IL-1β, IL-6, IL-17 and TNF-α in serum and expression of Bcl-2, p53, and Fas were also significantly decreased (p < 0.05) in CIA mice administered ZFTG, TGP, or CPA, whereas IL-10 levels increased.

Conclusion: These results suggest that ZFTG exhibit anti-rheumatic activity in CIA mice via modulation of inflammatory cytokines (IL-1β, IL-6, IL-10, IL-17 and TNF-α) and downregulation of the expressions of Bcl-2, p53, and Fas. Thus, ZFTG is a potential candidate drug for the treatment of RA.

Keywords: Zhuifengtougu pill, Rheumatoid arthritis, Cytokines, Bcl-2, Fas, p53



http://dx.doi.org/10.4314/tjpr.v17i12.19
AJOL African Journals Online